KLOW 80mg

KLOW is a multi-compound research formulation developed for laboratory investigation of connective tissue, cellular signaling, and regulatory pathway interactions. This blend contains:

• KPV (10mg) – a tripeptide fragment studied in research models for its interaction with inflammatory signaling pathways and immune-modulatory mechanisms.
• GHK-Cu (50mg) – a copper-binding peptide complex evaluated for its role in extracellular matrix regulation, antioxidant activity pathways, and tissue remodeling signaling.
• TB-500 (10mg) – a synthetic fragment of Thymosin Beta-4 investigated for its involvement in actin-binding regulation, cellular migration pathways, and tissue repair–associated signaling.
• BPC-157 (10mg) – a synthetic peptide fragment studied for its interaction with connective tissue biology and gastrointestinal structural integrity pathways.

Preclinical research has explored the combined interaction of these compounds in models focused on:

• Connective tissue regulatory mechanisms
• Cellular repair–associated signaling
• Extracellular matrix dynamics
• Inflammatory balance pathways

Available findings remain preliminary and highly dependent on study design, dosing structure, and experimental conditions.

This compound is not approved by the U.S. Food and Drug Administration. Retro Longevity supplies this formulation strictly for laboratory, research, and educational purposes under the supervision of appropriately licensed professionals. Not intended for human consumption.